{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:47:28Z","timestamp":1761518848016},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[1991,3,1]],"date-time":"1991-03-01T00:00:00Z","timestamp":667785600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[1991,3]]},"DOI":"10.1007\/bf02561368","type":"journal-article","created":{"date-parts":[[2007,2,8]],"date-time":"2007-02-08T08:20:55Z","timestamp":1170922855000},"page":"S2-S6","source":"Crossref","is-referenced-by-count":22,"title":["Future horizons for calcitonin: A U.S. perspective"],"prefix":"10.1007","volume":"49","author":[{"suffix":"Jr.","given":"John H.","family":"Carstens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel D.","family":"Feinblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02561368_CR1","first-page":"1","volume-title":"The calcitonins: physiology and pharmacology","author":"M Azria","year":"1989","unstructured":"Azria M (1989) The calcitonins: physiology and pharmacology. Karger, Basel, pp 1\u2013152"},{"key":"BF02561368_CR2","first-page":"11","volume-title":"Calcitonin 1980 chemistry, physiology, pharmacology and clinical aspects","author":"S Guttman","year":"1980","unstructured":"Guttman S (1980) Chemistry and structure-activity-relationship of natural and synthetic calcitonins. In: Pecile A (ed) Calcitonin 1980 chemistry, physiology, pharmacology and clinical aspects. Excerpta Medica, Amsterdam, pp 11\u201324"},{"key":"BF02561368_CR3","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/BF01927568","volume":"32","author":"T Morikawa","year":"1976","unstructured":"Morikawa T, Munekata E, Sakakibara S (1976) Synthesis of eel calcitonin and Asu eel calcitonin: contribution of the disulphide bond to the hormonal activity. Experientia 32:1104\u20131106","journal-title":"Experientia"},{"key":"BF02561368_CR4","unstructured":"Potts JR, Aurbach GD (1976) Chemistry of the calcitonins. In: Greep RO, Astwood EB (eds) Handbook of physiology. American Physiological Society 7\/7, p 423"},{"key":"BF02561368_CR5","first-page":"99","volume-title":"Calcitonin 1980: chemistry, physiology, pharmacology and clinical aspects","author":"G Segre","year":"1985","unstructured":"Segre G, Bruni G, Dal Pra P (1985) Calcitonin pharmacokinetics. In: Pecile (ed) Calcitonin 1980: chemistry, physiology, pharmacology and clinical aspects. Excerpta Medica, Amsterdam, pp 99\u2013107"},{"key":"BF02561368_CR6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/03009749009092626","volume":"19","author":"JY Reginster","year":"1990","unstructured":"Reginster JY, Gennari C, Mautalen C, et al (1990) Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone. Scand J Rheumatology 19:83\u201386","journal-title":"Scand J Rheumatology"},{"key":"BF02561368_CR7","first-page":"457","volume-title":"Calcitonin","author":"C Gennari","year":"1985","unstructured":"Gennari C, Gonnelli S, Chierichetti SM, et al (1985) Antibody problem in calcitonin administration. In: Pecile A (ed) Calcitonin. Elsevier Science Publishers BV, Amsterdam, pp 457\u2013467"},{"issue":"suppl","key":"BF02561368_CR8","first-page":"60","volume":"44","author":"C Gennari","year":"1989","unstructured":"Gennari C, Agnusdei D (1989) Gain in bone mass and duration of antiresorptive treatment in established osteoporosis. Calcif Tissue Int 44 (suppl):S60","journal-title":"Calcif Tissue Int"},{"key":"BF02561368_CR9","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1172\/JCI108865","volume":"60","author":"H Heath III","year":"1977","unstructured":"Heath H III, Sizemore GW (1977) Plasma calcitonin in normal man: differences between men and women. J Clin Invest 60:1135\u20131140","journal-title":"J Clin Invest"},{"key":"BF02561368_CR10","first-page":"272","volume":"29","author":"G Milhaud","year":"1980","unstructured":"Milhaud G, Benezech-Lefevre M, Moukhtar MS (1980) Deficiency of calcitonin in age related osteoporosis. Biomedicine 29:272\u2013276","journal-title":"Biomedicine"},{"key":"BF02561368_CR11","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1056\/NEJM198006123022407","volume":"302","author":"LJ Deftos","year":"1980","unstructured":"Deftos LJ, Weisman H, Williams GW, et al (1980) Influence of age and sex on plasma calcitonin in human beings. N Engl J Med 302:1351\u20131353","journal-title":"N Engl J Med"},{"key":"BF02561368_CR12","first-page":"556","volume":"22","author":"S Wallach","year":"1977","unstructured":"Wallach S, Cohn SH, Atkins HL, et al (1977) Effect of salmon calcitonin on skeletal mass in osteoporosis. Curr Ther Res 22:556\u2013572","journal-title":"Curr Ther Res"},{"key":"BF02561368_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0026-0495(84)90187-2","volume":"33","author":"HE Gruber","year":"1984","unstructured":"Gruber HE, Ivey JL, Baylink DJ, et al (1984) Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism 33:295\u2013303","journal-title":"Metabolism"},{"key":"BF02561368_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/BF02556587","volume":"38","author":"GF Mazzuoli","year":"1986","unstructured":"Mazzuoli GF, Passeri M, Gennari C, et al (1986) Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study. Calcif Tissue Int 38:3\u20138","journal-title":"Calcif Tissue Int"},{"key":"BF02561368_CR15","first-page":"455","volume":"38","author":"C Gennari","year":"1985","unstructured":"Gennari C, Chierichetti SM, Bigazzi S, et al (1985) Comparative effects on bone mineral content of calcium and calcium plus salmon calcitonin given in two different regimens in postmenopausal osteoporosis. Curr Ther Res 38:455\u2013464","journal-title":"Curr Ther Res"},{"key":"BF02561368_CR16","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1172\/JCI113725","volume":"82","author":"R Civitelli","year":"1988","unstructured":"Civitelli R, Gonnelli S, Zacchei F, et al (1988) Bone turnover in postmenopausal osteoporosis: effect of calcitonin treatment. Clin Invest 82:1268\u20131274","journal-title":"Clin Invest"},{"key":"BF02561368_CR17","first-page":"449","volume":"39","author":"PL Melanotte","year":"1986","unstructured":"Melanotte PL, Caira S (1986) Salmon calcitonin effect on proximal femur fracture repair in elderly patients. Curr Ther Res 39:449\u2013454","journal-title":"Curr Ther Res"},{"key":"BF02561368_CR18","first-page":"103","volume":"45","author":"LV Avioli","year":"1990","unstructured":"Avioli LV (1990) Calcitonin therapy in osteoporotic syndromes. JAMWA 45:103\u2013107","journal-title":"JAMWA"},{"key":"BF02561368_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF00610377","volume":"33","author":"JD Range","year":"1987","unstructured":"Range JD, Welzel D (1987) Salmon calcitonin in the therapy of corticoid-induced osteoporosis. Eur J Pharm 33:35\u201339","journal-title":"Eur J Pharm"},{"key":"BF02561368_CR20","first-page":"315","volume-title":"Calcitonin 1984: chemistry, physiology, pharmacology and clinical aspects","author":"GP Pasero","year":"1985","unstructured":"Pasero GP, Gennari C, Di Munno O, et al (1985) Prevention of glucocorticoid-induced osteopenia by calcitonin. In: Pecile A (ed) Calcitonin 1984: chemistry, physiology, pharmacology and clinical aspects. Excerpta Medica, Amsterdam, pp 315\u2013323"},{"key":"BF02561368_CR21","first-page":"157","volume":"22","author":"C Gennari","year":"1983","unstructured":"Gennari C (1983) Clinical aspects of calcitonin in pain. Triangle 22:157\u2013163","journal-title":"Triangle"},{"key":"BF02561368_CR22","first-page":"147","volume":"22","author":"A Pecile","year":"1983","unstructured":"Pecile A (1983) Calcitonin and pain relief. Triangle 22:147\u2013155","journal-title":"Triangle"},{"key":"BF02561368_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1055\/s-2007-1012291","volume":"18","author":"L Laurian","year":"1986","unstructured":"Laurian L, Oberman Z, Graf E, et al (1986) Calcitonin induced increase in ACTH, \u03b2-endorphin and cortisol secretion. Horm Metabol Res 18:268\u2013271","journal-title":"Horm Metabol Res"},{"key":"BF02561368_CR24","first-page":"119","volume-title":"Calcitonin 1984: selected short communications, International Calcitonin Symposium, Milan, 2\u20134 October 1984","author":"J Levernieux","year":"1984","unstructured":"Levernieux J, Julien D, Caulin F (1984) A double blind study on the effect of calcitonin on pain and acute resorption related to recent osteoporotic crush fractures. In: Doepfner W (ed) Calcitonin 1984: selected short communications, International Calcitonin Symposium, Milan, 2\u20134 October 1984, Excerpta Medica, Amsterdam, pp 119\u2013125"},{"key":"BF02561368_CR25","first-page":"89","volume-title":"Osteoporosis: epidemiology, clinical presentation, diagnosis and treatment","author":"KC Chan","year":"1988","unstructured":"Chan KC, Fang D (1988) MiacalcicR (synthetic salmon calcitonin) in osteoporotic bone pain. In: Chestnut III CH (ed) Osteoporosis: epidemiology, clinical presentation, diagnosis and treatment. Excerpta Medica Asia Ltd, Hong Kong, pp 89\u201393"},{"key":"BF02561368_CR26","first-page":"81","volume-title":"Osteoporosis: epidemiology, clinical presentation, diagnosis and treatment","author":"KS Lam","year":"1988","unstructured":"Lam KS (1988) Clinical evaluation of short term Miacalcic (synthetic salmon calcitonin) in osteoporotic bone pain. In: Chestnut III CH (ed) Osteoporosis: epidemiology, clinical presentation, diagnosis and treatment. Excerpta Medica Asia Ltd, Hong Kong, pp 81\u201386"},{"issue":"Suppl 1","key":"BF02561368_CR27","first-page":"399","volume":"4","author":"PM Vinceneux","year":"1989","unstructured":"Vinceneux PM, Pouchot JA (1989) Analgesic effect of salmon calcitonin in crushed vertebral fractures: double blind versus placebo studying 58 patients. J Bone Miner Res 4:(Suppl 1) S399","journal-title":"J Bone Miner Res"},{"key":"BF02561368_CR28","first-page":"298","volume":"38","author":"C Gennari","year":"1985","unstructured":"Gennari C, Chierichetti SM, Piolini M, et al (1985) Analgesic activity of salmon and human calcitonin against cancer pain: a double-blind, placebo-controlled clinical study. Curr Ther Res 38:298\u2013308","journal-title":"Curr Ther Res"},{"key":"BF02561368_CR29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/0753-3322(89)90088-7","volume":"43","author":"M Ustdal","year":"1989","unstructured":"Ustdal M, Dogan P, Soyuer A, et al (1989) Treatment of migraine with salmon calcitonin: effects on plasma beta-endorphin, ACTH and cortisol levels. Biomed Pharmacother 43:687\u2013691","journal-title":"Biomed Pharmacother"},{"key":"BF02561368_CR30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/030089168907500222","volume":"75","author":"S Miseria","year":"1989","unstructured":"Miseria S, Torresi U, Piga A, et al (1989) Analgesia with epidural calcitonin in cancer patients. Tumori 75:183\u2013184","journal-title":"Tumori"},{"key":"BF02561368_CR31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/00003495-198836020-00005","volume":"36","author":"JC Stevenson","year":"1988","unstructured":"Stevenson JC (1988) Current management of malignant hypercalcaemia. Drugs 36:229\u2013238","journal-title":"Drugs"},{"key":"BF02561368_CR32","first-page":"379","volume-title":"Calcitonin 1984: chemistry, physiology, pharmacology and clinical aspects","author":"C Zanussi","year":"1985","unstructured":"Zanussi C, Marini U, Ferrini PLR, et al (1985) Calcitonin in multiple myetoma: a double blind controlled clinical trial. In: Pecile A (ed) Calcitonin 1984: chemistry, physiology, pharmacology and clinical aspects. Excerpta Medica, Amsterdam, pp 379\u2013388"},{"key":"BF02561368_CR33","first-page":"85","volume":"77","author":"S Kimura","year":"1986","unstructured":"Kimura S, Sato Y, Matsubara H, et al (1986) A retrospective evaluation of the medical treatment of malignancy-associated hypercalcaemia. Jap J Can Res 77:85\u201391","journal-title":"Jap J Can Res"},{"key":"BF02561368_CR34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5694\/j.1326-5377.1983.tb104343.x","volume":"1","author":"RA Evans","year":"1983","unstructured":"Evans RA (1983) Treatment of Paget's disease of bone. Med J of Australia 1:159\u2013163","journal-title":"Med J of Australia"},{"key":"BF02561368_CR35","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1210\/jcem-56-2-405","volume":"56","author":"SH Toh","year":"1978","unstructured":"Toh SH, Claunch BC, Brown PH (1978) Effect of calcitonin treatment on the natural course of bone demineralization in Paget's disease. J Clin Endo Metab 56:405\u2013409","journal-title":"J Clin Endo Metab"},{"key":"BF02561368_CR36","first-page":"213","volume-title":"Molecular endocrinology","author":"C Nagant de Deuxchaisnes","year":"1977","unstructured":"Nagant de Deuxchaisnes C, Rombouts-Lindermans C, Huaux JP, et al (1977) Roentgenologic evaluation of the efficacy of calcitonin in Paget's bone disease. In: MacIntyre I, Szelke M (eds) Molecular endocrinology. Elsevier North Holland Biomedical Press, Amsterdam, pp 213\u2013233"},{"key":"BF02561368_CR37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1259\/0007-1285-50-598-699","volume":"50","author":"NJ Woodhouse","year":"1977","unstructured":"Woodhouse NJ, Chalmers AH, Wells IP, et al (1977) Paget's disease. Radiological changes occurring in untreated patients and those on salmon calcitonin therapy during two years' observation. Br J Radiol 50:699\u2013705","journal-title":"Br J Radiol"},{"key":"BF02561368_CR38","unstructured":"Data on file, Sandoz Pharmaceuticals."},{"key":"BF02561368_CR39","first-page":"65","volume":"54","author":"J Eisinger","year":"1987","unstructured":"Eisinger J (1987) Tolerance clinique de la calcitonine en function du mode d'administration. Revue du Rhumatisme 54:65\u201367","journal-title":"Revue du Rhumatisme"},{"key":"BF02561368_CR40","first-page":"155","volume":"3","author":"JY Reginster","year":"1985","unstructured":"Reginster JY, Franchimont P (1985) Side effects of synthetic salmon calcitonin given by intranasal spray compared with intramuscular injection. Clin and Exp Rheum 3:155\u2013157","journal-title":"Clin and Exp Rheum"},{"key":"BF02561368_CR41","first-page":"853","volume-title":"Osteoporosis","author":"C Christiansen","year":"1987","unstructured":"Christiansen C, Riis BJ, Podenphant J, et al (1987) Intranasal calcitonin in the treatment of postmenopausal osteoporosis. In: Christiansen C, Johansen JS, Riis BJ (eds) Osteoporosis. Osteopress, Copenhagen, pp 853\u2013856"},{"key":"BF02561368_CR42","first-page":"1271","volume-title":"Osteoporosi 1987","author":"MA Dambacher","year":"1987","unstructured":"Dambacher MA, Ruegsegger P, Goldmann AR, et al (1987) Treatment of postmenopausal osteoporosis with calcitonin nasal-spray evaluated with quantitative computed tomography. In: Christiansen C, Johansen JS, Riis BJ (eds) Osteoporosi 1987. Osteopress, Copenhagen, pp 1271\u20131272"},{"key":"BF02561368_CR43","first-page":"169","volume":"14","author":"D Agnusdei","year":"1989","unstructured":"Agnusdei D, Gonnelli S, Camporeale A, et al (1989) Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis. Minerva Endocrinologica 14:169\u2013176","journal-title":"Minerva Endocrinologica"},{"key":"BF02561368_CR44","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2265.1989.tb00443.x","volume":"30","author":"K Overgaard","year":"1989","unstructured":"Overgaard K, Riis BJ, Christiansen C, et al (1989) Nasal calcitonin for treatment of established osteoporosis. Clin Endo 30:435\u2013442","journal-title":"Clin Endo"},{"key":"BF02561368_CR45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/BF02556561","volume":"44","author":"RD Hesch","year":"1989","unstructured":"Hesch RD, Busch U, Prokop M, et al (1989) Increase of vertebral density by combination therapy with pulsatile 1-38hPTH and sequential addition of calcitonin nasal spray in osteoporotic patients. Calcif Tissue Int 44:176\u2013180","journal-title":"Calcif Tissue Int"},{"key":"BF02561368_CR46","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/S0140-6736(87)92619-5","volume":"2","author":"JY Reginster","year":"1987","unstructured":"Reginster JY, Denis D, Albert A, et al (1987) One-year, controlled, randomized trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet 2:1481\u20131483","journal-title":"Lancet"},{"issue":"Suppl 1","key":"BF02561368_CR47","first-page":"162","volume":"3","author":"K Overgaard","year":"1988","unstructured":"Overgaard K, Riis BJ, Christiansen C (1988) The role of intranasal calcitonin in the treatment and prophylaxis of postmenopausal osteoporosis. J Bone Min Res 3 (Suppl 1):S162","journal-title":"J Bone Min Res"},{"key":"BF02561368_CR48","first-page":"205","volume":"11","author":"KK Pun","year":"1989","unstructured":"Pun KK, Chan LW (1989) Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures. Clin Therapeutics 11:205\u2013209","journal-title":"Clin Therapeutics"},{"key":"BF02561368_CR49","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/BF02554908","volume":"37","author":"JY Reginster","year":"1985","unstructured":"Reginster JY, Albert A, Franchimont P (1985) Salmon calcitonin nasal spray in Paget's disease of bone: preliminary results in five patients. Calcif Tissue Int 37:577\u2013580","journal-title":"Calcif Tissue Int"},{"key":"BF02561368_CR50","first-page":"329","volume-title":"Calcitonin 1984","author":"C Nagant de Deuxchaisnes","year":"1985","unstructured":"Nagant de Deuxchaisnes C, Devogelaer JP, Huaux JP, et al (1985) Effect of a nasal spray of salmon calcitonin in normal subjects and in patients with Paget's disease of bone. In: Pecile A (ed) Calcitonin 1984. Elsevier Science Publishers. Amsterdam, pp 329\u2013343"},{"key":"BF02561368_CR51","first-page":"599","volume":"80","author":"A Giustina","year":"1989","unstructured":"Giustina A, Macca C, Romanelli G, et al (1989) Salmon calcitonin nasal spray in the treatment of Paget's disease 80:599\u2013602","journal-title":"Salmon calcitonin nasal spray in the treatment of Paget's disease"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02561368.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02561368\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02561368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02561368.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T18:12:18Z","timestamp":1581963138000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02561368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,3]]},"references-count":51,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[1991,3]]}},"alternative-id":["BF02561368"],"URL":"https:\/\/doi.org\/10.1007\/bf02561368","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,3]]}}}